Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Colorectal Neoplasms 44 Pancreatic Neoplasms 17 Stomach Neoplasms 16 Neoplasm Metastasis 11 Rectal Neoplasms 10 Neoplasms 10 Colonic Neoplasms 7 Adenocarcinoma 7 Carcinoma, Non-Small-Cell Lung 6 Carcinoma, Hepatocellular 6 Gastrointestinal Neoplasms 5 Biliary Tract Neoplasms 5 Esophageal Neoplasms 4 Cholangiocarcinoma 4 Burkitt Lymphoma 4 Advanced Solid Tumors 4 Adenocarcinoma Of Esophagus 4 Leukemia, Biphenotypic, Acute 3 Esophageal Squamous Cell Carcinoma 3 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Peritoneal Neoplasms 2 Ovarian Neoplasms 2 Locally Recurrent Rectal Cancer 2 Gallbladder Neoplasms 2 Endometrial Neoplasms 2 Appendiceal Neoplasms 2 Uterine Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Solid Tumors 1

Interventions

folfirinox 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Fluorouracil 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ampullary Adenocarcinoma × Leucovorin × Clear all

NCT06068023 2023-10-05

ADAPTA

Fondazione Poliambulanza Istituto Ospedaliero

Ampullary Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡